(Q43511633)

24 November 2017

title

Cause of high variability in drug dissolution testing and its impact on setting tolerances (English)

1 reference

24 November 2017

Qureshi SA

1

1 reference

24 November 2017

Shabnam J

series ordinal

2

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

European Journal of Pharmaceutical Sciences

24 November 2017

published in

1 reference

24 November 2017

volume

12

1 reference

24 November 2017

issue

3

1 reference

24 November 2017

page(s)

271-276

1 reference

Systematic error associated with apparatus 2 of the USP dissolution test II: Effects of deviations in vessel curvature from that of a sphere.

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900174-3

7 January 2021

Systematic error associated with apparatus 2 of the USP dissolution test IV: effect of air dissolved in the dissolution medium

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900174-3

7 January 2021

Systematic error associated with apparatus 2 of the USP dissolution test V: Interaction of two tableted prednisone formulations with glass and plastic vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900174-3

7 January 2021

Assessment of pharmaceutical quality of furosemide tablets from multinational markets

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900174-3

7 January 2021

Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900174-3

7 January 2021

10.1016/S0928-0987(00)00174-3

Identifiers

DOI

1 reference

24 November 2017

1 reference